Rovi Corp. (ROVI), DISH Network (DISH) Enter 10-Year Patent Renewal Licensing Agreement
- Wall Street hits new high as post-election rally roars ahead
- ECB to scale back asset buys as it extends to end-2017
- lululemon athletica (LULU) Tops Q3 EPS by 4c; Adj.-Comps Outpaced Views
- Oil rises above $50 despite doubts over OPEC output cut
- Pre-Open Stock Movers 12/08: (VYGR) (TLRD) (LULU) Higher; (OHRP) (VRNT) (CMTL) Lower (more...)
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Rovi Corporation (Nasdaq: ROVI) announced that it signed a 10-year patent renewal license agreement with DISH Network L.L.C., a subsidiary of DISH Network Corporation (Nasdaq: DISH). In addition, this agreement will continue DISH’s license to Rovi’s Conversation Services natural language platform, as well as other Rovi products.
Tom Carson, president and CEO of Rovi, said, “Our renewal with DISH further validates the long-term value and relevance of our intellectual property portfolio, reinforcing the importance of Rovi’s intellectual property (IP) with both traditional and next-generation pay-TV service providers. With this most recent renewal, Rovi now has nine of the top 10 U.S. pay-TV operators under license, with significant recent momentum, as seven of those agreements have been signed over the last seven quarters.”
Rovi’s quarter-century of investment in research and development has enabled it to generate one of the world’s leading media and entertainment patent and product portfolios. The company’s commitment to innovation enables the delivery of products that touch practically every aspect of consumers’ day-to-day interaction with their entertainment, and helps licensees build customized, next-generation digital entertainment solutions for users around the globe.
The patent license renewal is subject to certain contingencies relating to the closing of Rovi’s acquisition of TiVo Inc., which we expect to become effective on September 7, 2016, subject to obtaining the approval of the TiVo and Rovi stockholders and satisfaction of other customary closing conditions. For further details on the terms of this license agreement, please see Rovi’s Current Report on Form 8-K filed today.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LinkedIn (LNKD), Microsoft (MSFT) Deal Closes
- Catyalyst Pharma (CPRX) Updates on Amifampridine Phosphate Trial in CMS Patients
- Horizon Pharma (HZNP) Announces ACTIMMUNE Phase 3 in FA Missed Primary Endpoint
Create E-mail Alert Related CategoriesCorporate News, Litigation, Management Comments
Related EntitiesTwitter, Definitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!